53 Kossuth St., Somerset, NJ  08873 Tel: 732-565-9224

105 Morris Avenue, Suite 200,Springfield, NJ  07081 Tel:  973-218-9191

Anxiety and Stress-Related Disorders

Autistic Spectrum Disorders (Including Asperger's Syndrome, Pervasive Development Disorder (PDD), and Attention Deficit Disorder)

Candida Treatments

Chronic Fatigue Syndrome

Chronic Fatigue HHV-6 Treatment

Chronic Fatigue Syndrome Disability

Depression

Fibromyalgia

Fibromyalgia News

Fibromyalgia Disability

Hypoglycemia

Postherpetic Neuralgia (PHN)

Shingles Treatment

Thyroid and Hypothyroidism

Yeast Infection Treatments

Resources


Information for New Patients

New Patient Information Forms (PDF)


Reversing Eight Vicious Cycles That Block Normal Healing

Safety Concerns

Recent Updates


Our New Jersey Offices

Union County, New Jersey:
105 Morris Avenue, Suite 200, Springfield, NJ  07081
Tel:  973-218-9191
Fax:  973-218-1199
 
Somerset County, New Jersey:
53 Kossuth Street
Somerset NJ 08873
Tel:  732-565-9224 
Fax:  732-565-9225

Serving patients from New Jersey (NJ), New York (NY), Pennsylvania (Pa), and Connecticutt (CT)


 

Chronic Fatigue Syndrome HHV-6-Possible Cure?
Physicians Encouraged by Valcyte.

CHRONIC FATIGUE SYNDROME HHV-6 -- Powerful anti-viral drug, Valcyte’s potential as chronic fatigue syndrome cure.

Chronic fatigue syndrome HHV-6 may be an excitingly effective treatment

Dr. Jose Montoya, a chronic fatigue syndrome physician at Stanford Medical School, treated 25 chronic fatigue syndrome (CFS) patients with Valcyte, an oral medicine that blocks HHV-6, Epstein Barr virus and other Herpes family viruses.[1]

Spectacularly, 21 of 25 patients dramatically improved. Most achieved near resolution of their CFS symptoms after a six month course of treatment. This allowed return to work or other full-time activities. Of those whose CFS had begun with a flu-like illness, 20 out of 21 gained improved health.

For the Abstract of Dr. Montoya’s article on chronic fatigue syndrome HHV-6 treatment This is the National Library of Medicine’s website. In the search space type the words — chronic fatigue syndrome Montoya Valcyte. Click Here.

For an update on Dr. Montoya’s more recent progress, this will take you to Stanford Medical School’s website. Enter search terms Montoya and fatigue. Then click on the on the title New Therapy For Chronic Fatigue Syndrome Click Here.

If confirmed by further studies, Dr. Montoya’s research tells us two important facts:

o HHV-6 and/or  Epstein Barr Virus can cause Chronic Fatigue Syndrome

o Valcyte might be an effective treatment for Chronic Fatigue Syndrome HHV-6  related illness, perhaps, even a chronic fatigue syndrome cure.

[1] (HHV 6 stands for Herpes Virus 6, the sixth virus in the Herpes family. The standard spelling is HHV-6, but we also see it as HHV 6 and HHV6. Chronic fatigue syndrome physicians believe that Chronic Fatigue Syndrome HHV-6 may affect up to 50% of CFS patients. Other Herpes family viruses include Epstein Barr virus (EBV), Cytomegalovirus (CMV), Herpes Simplex (oral and genital) and also chicken pox virus (Varicella Zoster).


Structure of the HHV-6 virus. Anti-viral treatment for Chronic Fatigue Syndrome HHV-6 increases hope chronic fatigue syndrome cure.

Roche Pharmaceuticals recently gave Dr. Montoya and his chronic fatigue syndrome physician team $1.3 million to do a double-blind study to confirm Valcyte’s effectiveness as a chronic fatigue syndrome HHV-6 treatment. However, results might not be available for at least a year or more

back to top 


Chronic Fatigue Syndrome HHV-6:

How Chronic Fatigue Syndrome Physicians Tell the Difference Between Active HHV-6 Infection–which should be treated– and latent/ inactive infection–which should not.

Chronic fatigue syndrome physicians are concerned about this problem: Since almost everyone has had an HHV-6 infection at some point, latent inactive HHV-6 is present in most of us. That’s why perhaps 80% of healthy people show up positive on standard blood antibody tests for HHV-6. But, while for most people HHV-6 remains inactive for life, chronic fatigue physicians believe that in a few people a triggering event happens. This causes latent virus to become active, aggressive and infectious. The result: chronic fatigue syndrome HHV 6 –active CFS!

Chronic Fatigue Syndrome HHV-6 Pathways: How Latent Virus Infection can turn into symptomatic, active CFS Illness. Can HHV-6 treatment be a chronic fatigue syndrome cure? (Courtesy of the Wisconsin Viral Research Group)


Click Picture For Larger View

 

back to top 


Which Diagnostic Tests Help Chronic Fatigue Syndrome physicians decide whether your HHV-6 is active or latent? Do you have active chronic fatigue syndrome HHV-6?

Blood antibody tests for HHV-6 are available through many commercial laboratories. Such blood antibody tests are helpful but not definitive. Many people are positive for HHV-6; but the higher the antibody levels, the odds increase that you might have active chronic fatigue syndrome HHV-6.  But the antibody test is far from perfect. Some persons with relatively low antibody levels have active HHV-6. Some people with high antibody levels don’t.

Blood Culture and Antigen test for HHV-6: The Wisconsin Research Group offers a Herpes virus culture test. Their lab is the best for HHV-6 testing. While standard antibody tests against HHV-6 also should be done, the Wisconsin test may be more accurate. Ideally you should have the standard test and also the Wisconsin test before making a decision about Valcyte treatment for CFS.

Nested PCR: The Wisconsin Viral Research Group also offers a sophisticated test to detect actual virus particles in the blood. This is called nested PCR. The Wisconsin Viral Research Group version is more sensitive and accurate than the standard PCR.

If you have high HHV-6 antibody levels and a positive Herpes Virus 6 culture, consider the pros and cons of Valcyte treatment for your chronic fatigue syndrome.

For more information on chronic fatigue syndrome HHV-6 testing visit the website of the  HHV-6 Foundation.

For the Wisconsin Viral Research Group visit chronic fatigue syndrome HHV-6  Testing.

 back to top


Cautions and Warnings About Valcyte as A Chronic Fatigue Syndrome Treatment

Dr. Montoya’s 25 CFS patients did not suffer dangerous side effects when he treated them with Valcyte. However chronic fatigue syndrome physicians are also very clear: Valcyte is a drug with potential toxicity.

The body converts Valcyte into Ganciclovir, a well established but potentially toxic anti-viral medicine. Valcyte is approved by the FDA to treat CMV virus. It does not have an FDA indication for HHV-6 or as a treatment for chronic fatigue syndrome.

Potential side-effects of Valcyte/Ganciclovir include suppression of white blood cells, red blood cells and/or platelets. Low white blood cells increases risk for infection; low red blood cells causes anemia; low platelets increase risk for bleeding. If not monitored, detected and reversed, these complications can be fatal. Fortunately, side-effects can usually be reversed by stopping the Valcyte or by lowering its dose.

For Chronic Fatigue Syndrome HHV 6 and other Valcyte treatments, CFS patients should have blood tests monitored often  (e.g. weekly).

 Valcyte’s side effects can also include nausea, diarrhea, abdominal pain, fever, headache, insomnia, mood changes, tingling sensation--and much less commonly, epileptic seizures. In animal studies, ganciclovir can cause cancer.

back to top


If Valcyte/Ganciclovir is so dangerous, why would chronic fatigue syndrome physicians consider it as a potential treatment for chronic fatigue syndrome HHV-6?

A good question, and there’s a good answer.  We have no effective drug treatments for chronic fatigue syndrome at present. If your illness is severe enough, the potential benefit from Valcyte treatment for chronic fatigue syndrome HHV6, might reasonably be considered to be worth the potential risk. That’s the key decision that you and your physicians have to make.

Consider this analogy to chronic fatigue syndrome HHV 6. If you had cancer or disabling rheumatoid arthritis or chronic hepatitis, specialists routinely recommend medicines that are as or more toxic than Valcyte. So too for chronic fatigue syndrome HHV 6. One weighs the risks of adding Valcyte treatment against the risks of not treating and letting the disease “take its course”. Not an easy decision—since until double blind studies are done we can’t really know if this anti-viral drug might be a chronic fatigue syndrome cure.

back to top


Dr. Podell’s Perspective on Chronic Fatigue Syndrome HHV6 Treatment with Valcyte/Ganciclovir:

As a chronic fatigue syndrome physician, I recommend that persons whose CFS allows them a decent quality of life should not take Valcyte at this time. But, do test blood antibodies and/or  Herpes virus culture. Keep up to date on this potential treatment option, especially as safer anti Herpes drugs become available.

For the most reliable and up-to-date information about chronic fatigue syndrome HHV-6 go to www.Pubmed.gov the data base site for the National Library of Medicine. Enter the keywords Chronic Fatigue Syndrome HHV-6, and/or Chronic Fatigue Syndrome Treatment HHV-6.

 While waiting for further news  consider adding relatively non-toxic natural immune system stimulants to your chronic fatigue syndrome treatment program e.g. high dose Lactobacillus Acidophilus, HHV-6 transfer factor, or Fungal cell wall immune stimulants such as AHCC or Peak Immune Factor 4.

Do CONSIDER Valcyte treatment for chronic fatigue syndrome HHV-6 if your CFS is severe and disabling. We don’t have double blind studies; but the encouraging results Dr. Montoya reported should make us optimistic that Valcyte, indeed, might be a useful treatment.

In our New Jersey (NJ) office, we take these steps to evaluate an individual’s potential use of Valcyte for Chronic Fatigue Syndrome HHV6 Treatment:

  1. Confirm that you really have chronic fatigue syndrome, not one of the many other conditions that can mimic CFS.

  2. Look for other treatable aspects of your illness e.g. unrecognized low thyroid, sleep apnea, adrenal gland problems, inadequate nutrition, anxiety or depression.

  3. Add natural holistic nutritional, herbal and/or mind-body treatments to support the body’s natural ability to heal.

  4. Be sure that social and psychological supports are in place to help you and your family cope better with the illness.

  5. Test HHV-6 antibody levels and HHV-6 culture and antigen tests.

  6. Ask you to read the FDA-approved drug package insert for Valcyte. (Click Here for Valcyte Treatment for Chronic Fatigue Syndrome Package Insert)

  7. Before starting Valcyte through  Dr. Podell’s offices in Springfield or Somerset  New Jersey (NJ) CFS patients should agree to a firm schedule of regular laboratory test monitoring. Valcyte patients would see Dr. Podell at least monthly during an estimated six month course of treatment.  Blood test monitoring for Valcyte toxicity is twice weekly for the first six weeks, then once every week.

For persons with chronic fatigue syndrome HHV6 or EBV who live in New York (NY), Pennsylvania (PA) or more than one hour away from our Springfield or Somerset New Jersey (N.J.) offices, Dr. Podell can perform the necessary evaluation for chronic fatigue syndrome HHV-6 within two or three visits. Dr. Podell can then consult with a physician near you, who, if you decide to take Valcyte, can directly supervise the treatment.

For chronic fatigue syndrome evaluation call  Dr.Podell's office 973-218-9191.

Also Visit:

  1. Our Chronic Fatigue Syndrome Main Page

  2. Chronic Fatigue Syndrome HHV-6 patient information handout

back to top

 

Dr. Podell Co-Hosts the Willner Window Radio Program

Dr. Podell Appearing on WNBC News 4 New York with Max Gomez

Video provided by WNBC

Please note: Physicians are not permitted to give specific advice or answer medical questions for individuals who have not been evaluated as patients